Comparison BridgeBio Oncology Therapeutics Inc Com (BBOT) with Competitors
BridgeBio Oncology Therapeutics Inc Com (BBOT) industry is Biotechnology.
Free Cash Flow Yield
BBOT-11.77%
Industry-1.75%
Upside-10.02%
P/E
BBOT-5.02
Industry-20.52
Upside+1549.86%
P/B
BBOT1.90
Industry5.15
Upside-63.08%